Shared decision‐making related to treatment of haemophilia: A scoping review of influential factors and available support tools

Introduction Treatment selection in haemophilia is increasingly challenging given evolving therapeutic options and the need for individualization. Shared decision‐making (SDM) approaches have recently gained interest, though a synthesis of available studies is lacking. Aim A scoping review was condu...

Celý popis

Uložené v:
Podrobná bibliografia
Vydané v:Haemophilia : the official journal of the World Federation of Hemophilia Ročník 30; číslo 4; s. 880 - 893
Hlavní autori: Sun, Haowei (Linda), Klaassen, Robert J., Anger, Dana L., Mendell, Ari L., Olatunde, Shade
Médium: Journal Article
Jazyk:English
Vydavateľské údaje: England Wiley Subscription Services, Inc 01.07.2024
Predmet:
ISSN:1351-8216, 1365-2516, 1365-2516
On-line prístup:Získať plný text
Tagy: Pridať tag
Žiadne tagy, Buďte prvý, kto otaguje tento záznam!
Abstract Introduction Treatment selection in haemophilia is increasingly challenging given evolving therapeutic options and the need for individualization. Shared decision‐making (SDM) approaches have recently gained interest, though a synthesis of available studies is lacking. Aim A scoping review was conducted to summarize literature reporting on factors impacting treatment SDM in haemophilia and tools or models available to support such decisions. Methods PubMed, Embase, the Cochrane Library, Web of Science and grey literature were searched for studies published through August 2023. Original studies reporting on facilitators and barriers to haemophilia SDM and SDM tools were included and analyzed for themes, characteristics and gaps. Results A total of 625 records were identified and 14 unique studies were selected (factors influencing treatment SDM, n = 7; SDM tools, n = 7). The studies typically included input from persons with haemophilia, caregivers and healthcare practitioners (HCPs). Thematic organization of factors influencing SDM revealed three main categories: knowledge, patient characteristics and HCP‐patient interactions. Availability of information was a commonly reported facilitator of SDM, while poor HCP‐patient engagement was a commonly reported barrier. Tools varied in focus, with some facilitating general treatment SDM while others supported selection of certain therapy types. The studies underscored additional factors critical for SDM, such as alignment of HCP‐patient perceptions, shared language and tailoring of tools to specific subpopulations. Conclusion Few studies report on treatment SDM factors and tools in haemophilia; available tools vary considerably. It remains unclear whether published tools have been successfully implemented into clinical practice. Additional research is warranted.
AbstractList Treatment selection in haemophilia is increasingly challenging given evolving therapeutic options and the need for individualization. Shared decision-making (SDM) approaches have recently gained interest, though a synthesis of available studies is lacking. A scoping review was conducted to summarize literature reporting on factors impacting treatment SDM in haemophilia and tools or models available to support such decisions. PubMed, Embase, the Cochrane Library, Web of Science and grey literature were searched for studies published through August 2023. Original studies reporting on facilitators and barriers to haemophilia SDM and SDM tools were included and analyzed for themes, characteristics and gaps. A total of 625 records were identified and 14 unique studies were selected (factors influencing treatment SDM, n = 7; SDM tools, n = 7). The studies typically included input from persons with haemophilia, caregivers and healthcare practitioners (HCPs). Thematic organization of factors influencing SDM revealed three main categories: knowledge, patient characteristics and HCP-patient interactions. Availability of information was a commonly reported facilitator of SDM, while poor HCP-patient engagement was a commonly reported barrier. Tools varied in focus, with some facilitating general treatment SDM while others supported selection of certain therapy types. The studies underscored additional factors critical for SDM, such as alignment of HCP-patient perceptions, shared language and tailoring of tools to specific subpopulations. Few studies report on treatment SDM factors and tools in haemophilia; available tools vary considerably. It remains unclear whether published tools have been successfully implemented into clinical practice. Additional research is warranted.
IntroductionTreatment selection in haemophilia is increasingly challenging given evolving therapeutic options and the need for individualization. Shared decision‐making (SDM) approaches have recently gained interest, though a synthesis of available studies is lacking.AimA scoping review was conducted to summarize literature reporting on factors impacting treatment SDM in haemophilia and tools or models available to support such decisions.MethodsPubMed, Embase, the Cochrane Library, Web of Science and grey literature were searched for studies published through August 2023. Original studies reporting on facilitators and barriers to haemophilia SDM and SDM tools were included and analyzed for themes, characteristics and gaps.ResultsA total of 625 records were identified and 14 unique studies were selected (factors influencing treatment SDM, n = 7; SDM tools, n = 7). The studies typically included input from persons with haemophilia, caregivers and healthcare practitioners (HCPs). Thematic organization of factors influencing SDM revealed three main categories: knowledge, patient characteristics and HCP‐patient interactions. Availability of information was a commonly reported facilitator of SDM, while poor HCP‐patient engagement was a commonly reported barrier. Tools varied in focus, with some facilitating general treatment SDM while others supported selection of certain therapy types. The studies underscored additional factors critical for SDM, such as alignment of HCP‐patient perceptions, shared language and tailoring of tools to specific subpopulations.ConclusionFew studies report on treatment SDM factors and tools in haemophilia; available tools vary considerably. It remains unclear whether published tools have been successfully implemented into clinical practice. Additional research is warranted.
Treatment selection in haemophilia is increasingly challenging given evolving therapeutic options and the need for individualization. Shared decision-making (SDM) approaches have recently gained interest, though a synthesis of available studies is lacking.INTRODUCTIONTreatment selection in haemophilia is increasingly challenging given evolving therapeutic options and the need for individualization. Shared decision-making (SDM) approaches have recently gained interest, though a synthesis of available studies is lacking.A scoping review was conducted to summarize literature reporting on factors impacting treatment SDM in haemophilia and tools or models available to support such decisions.AIMA scoping review was conducted to summarize literature reporting on factors impacting treatment SDM in haemophilia and tools or models available to support such decisions.PubMed, Embase, the Cochrane Library, Web of Science and grey literature were searched for studies published through August 2023. Original studies reporting on facilitators and barriers to haemophilia SDM and SDM tools were included and analyzed for themes, characteristics and gaps.METHODSPubMed, Embase, the Cochrane Library, Web of Science and grey literature were searched for studies published through August 2023. Original studies reporting on facilitators and barriers to haemophilia SDM and SDM tools were included and analyzed for themes, characteristics and gaps.A total of 625 records were identified and 14 unique studies were selected (factors influencing treatment SDM, n = 7; SDM tools, n = 7). The studies typically included input from persons with haemophilia, caregivers and healthcare practitioners (HCPs). Thematic organization of factors influencing SDM revealed three main categories: knowledge, patient characteristics and HCP-patient interactions. Availability of information was a commonly reported facilitator of SDM, while poor HCP-patient engagement was a commonly reported barrier. Tools varied in focus, with some facilitating general treatment SDM while others supported selection of certain therapy types. The studies underscored additional factors critical for SDM, such as alignment of HCP-patient perceptions, shared language and tailoring of tools to specific subpopulations.RESULTSA total of 625 records were identified and 14 unique studies were selected (factors influencing treatment SDM, n = 7; SDM tools, n = 7). The studies typically included input from persons with haemophilia, caregivers and healthcare practitioners (HCPs). Thematic organization of factors influencing SDM revealed three main categories: knowledge, patient characteristics and HCP-patient interactions. Availability of information was a commonly reported facilitator of SDM, while poor HCP-patient engagement was a commonly reported barrier. Tools varied in focus, with some facilitating general treatment SDM while others supported selection of certain therapy types. The studies underscored additional factors critical for SDM, such as alignment of HCP-patient perceptions, shared language and tailoring of tools to specific subpopulations.Few studies report on treatment SDM factors and tools in haemophilia; available tools vary considerably. It remains unclear whether published tools have been successfully implemented into clinical practice. Additional research is warranted.CONCLUSIONFew studies report on treatment SDM factors and tools in haemophilia; available tools vary considerably. It remains unclear whether published tools have been successfully implemented into clinical practice. Additional research is warranted.
Introduction Treatment selection in haemophilia is increasingly challenging given evolving therapeutic options and the need for individualization. Shared decision‐making (SDM) approaches have recently gained interest, though a synthesis of available studies is lacking. Aim A scoping review was conducted to summarize literature reporting on factors impacting treatment SDM in haemophilia and tools or models available to support such decisions. Methods PubMed, Embase, the Cochrane Library, Web of Science and grey literature were searched for studies published through August 2023. Original studies reporting on facilitators and barriers to haemophilia SDM and SDM tools were included and analyzed for themes, characteristics and gaps. Results A total of 625 records were identified and 14 unique studies were selected (factors influencing treatment SDM, n = 7; SDM tools, n = 7). The studies typically included input from persons with haemophilia, caregivers and healthcare practitioners (HCPs). Thematic organization of factors influencing SDM revealed three main categories: knowledge, patient characteristics and HCP‐patient interactions. Availability of information was a commonly reported facilitator of SDM, while poor HCP‐patient engagement was a commonly reported barrier. Tools varied in focus, with some facilitating general treatment SDM while others supported selection of certain therapy types. The studies underscored additional factors critical for SDM, such as alignment of HCP‐patient perceptions, shared language and tailoring of tools to specific subpopulations. Conclusion Few studies report on treatment SDM factors and tools in haemophilia; available tools vary considerably. It remains unclear whether published tools have been successfully implemented into clinical practice. Additional research is warranted.
Author Sun, Haowei (Linda)
Anger, Dana L.
Olatunde, Shade
Klaassen, Robert J.
Mendell, Ari L.
Author_xml – sequence: 1
  givenname: Haowei (Linda)
  orcidid: 0000-0002-0205-9722
  surname: Sun
  fullname: Sun, Haowei (Linda)
  email: lsun3@ualberta.ca
  organization: University of Alberta
– sequence: 2
  givenname: Robert J.
  orcidid: 0000-0002-6913-2808
  surname: Klaassen
  fullname: Klaassen, Robert J.
  organization: University of Ottawa Children's Hospital of Eastern Ontario
– sequence: 3
  givenname: Dana L.
  orcidid: 0009-0001-7385-7297
  surname: Anger
  fullname: Anger, Dana L.
  organization: WRITRIX Medical Communications Inc
– sequence: 4
  givenname: Ari L.
  surname: Mendell
  fullname: Mendell, Ari L.
  organization: Compass Leaf Medical Communications Inc
– sequence: 5
  givenname: Shade
  surname: Olatunde
  fullname: Olatunde, Shade
  organization: Hoffmann‐La Roche Limited
BackLink https://www.ncbi.nlm.nih.gov/pubmed/38684450$$D View this record in MEDLINE/PubMed
BookMark eNp10c1uFSEUB3BiauyHLnwBQ-KmLqblY5hh3N001Zo0caGuCZc5eKkMjMC06U7fwGf0SeR6bzeNsoGE3zmQ_zlGByEGQOglJWe0rvONhjMqCOueoCPKO9EwQbuD7VnQRjLaHaLjnG8IoZyR7hk65LKTbSvIEfr5aaMTjHgE47KL4fePX5P-5sJXnMDrUm9KxCWBLhOEgqPF9bEpzhvnnX6LVzibOO_4rYO7LXDB-qVipz222pSYMtZhxPpWO6_XHnBe5jmmUltHn5-jp1b7DC_2-wn68u7y88VVc_3x_YeL1XVjuJRdAx1QOtieMMNFBy1lYz-YoWW91tIyKQWhzJLRck6AjoxRIg0BO1BLCRvW_ASd7vrOKX5fIBc1uWzAex0gLllx0g49Y73glb5-RG_ikkL9XVWStrIlYqjq1V4t6wlGNSc36XSvHsKt4HwHTIo5J7DKuKJLTbmkGoWiRG3Hp2qi6u_4asWbRxUPTf9l993vnIf7_0N1tbrcVfwBel6p7w
CitedBy_id crossref_primary_10_1111_hae_70062
crossref_primary_10_1111_hae_70054
crossref_primary_10_1111_hae_70015
crossref_primary_10_1080_17474086_2025_2554652
Cites_doi 10.2147/PPA.S355627
10.1136/bmjopen-2019-031763
10.1371/journal.pone.0191747
10.1182/blood-2020-136728
10.1177/2040620718784830
10.2478/jhp-2022-0021
10.1177/2040620717746312
10.1186/s13023-020-01555-w
10.2147/JMDH.S93579
10.1111/j.1365-2516.2009.02127.x
10.1111/hae.12495
10.1111/hae.14822
10.1016/j.blre.2023.101118
10.1016/j.jclinepi.2016.01.021
10.1016/j.blre.2021.100890
10.7326/M19-1208
10.7326/M18-0850
10.2147/PPA.S394095
10.1111/hae.14046
10.17225/jhp00178
10.1111/hae.14608
10.1182/asheducation-2017.1.595
10.2147/PPA.S406894
10.1002/pbc.26865
10.1111/hae.13830
10.1186/s40064-016-3086-4
10.1111/j.1365-2516.2011.02588.x
10.1177/20406207231165857
10.1016/j.pec.2023.107801
10.1111/hae.13766
10.1016/j.pec.2018.11.005
10.1007/s11606-012-2077-6
ContentType Journal Article
Copyright 2024 The Authors. published by John Wiley & Sons Ltd.
2024 The Authors. Haemophilia published by John Wiley & Sons Ltd.
2024. This article is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Copyright_xml – notice: 2024 The Authors. published by John Wiley & Sons Ltd.
– notice: 2024 The Authors. Haemophilia published by John Wiley & Sons Ltd.
– notice: 2024. This article is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
DBID 24P
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7T5
8FD
FR3
H94
K9.
P64
RC3
7X8
DOI 10.1111/hae.15026
DatabaseName Wiley Online Library Open Access
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Immunology Abstracts
Technology Research Database
Engineering Research Database
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
Biotechnology and BioEngineering Abstracts
Genetics Abstracts
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Genetics Abstracts
Technology Research Database
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
Immunology Abstracts
Engineering Research Database
Biotechnology and BioEngineering Abstracts
MEDLINE - Academic
DatabaseTitleList MEDLINE
Genetics Abstracts
MEDLINE - Academic

Database_xml – sequence: 1
  dbid: 24P
  name: Wiley Online Library Open Access
  url: https://authorservices.wiley.com/open-science/open-access/browse-journals.html
  sourceTypes: Publisher
– sequence: 2
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: 7X8
  name: MEDLINE - Academic
  url: https://search.proquest.com/medline
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1365-2516
EndPage 893
ExternalDocumentID 38684450
10_1111_hae_15026
HAE15026
Genre reviewArticle
Journal Article
Scoping Review
GrantInformation_xml – fundername: Hoffmann‐La Roche Limited
– fundername: Hoffmann-La Roche Limited
GroupedDBID ---
.3N
.GA
.Y3
05W
0R~
10A
1OB
1OC
24P
29I
31~
33P
36B
3SF
4.4
50Y
50Z
51W
51X
52M
52N
52O
52P
52R
52S
52T
52U
52V
52W
52X
53G
5GY
5HH
5LA
5VS
66C
702
7PT
8-0
8-1
8-3
8-4
8-5
8UM
930
A01
A03
AAESR
AAEVG
AAHHS
AAHQN
AAIPD
AAKAS
AAMNL
AANHP
AANLZ
AAONW
AASGY
AAXRX
AAYCA
AAZKR
ABCQN
ABCUV
ABDBF
ABEML
ABJNI
ABPVW
ABQWH
ABXGK
ACAHQ
ACBWZ
ACCFJ
ACCZN
ACGFO
ACGFS
ACGOF
ACMXC
ACPOU
ACPRK
ACRPL
ACSCC
ACUHS
ACXBN
ACXQS
ACYXJ
ADBTR
ADEOM
ADIZJ
ADKYN
ADMGS
ADNMO
ADOZA
ADXAS
ADZCM
ADZMN
ADZOD
AEEZP
AEGXH
AEIGN
AEIMD
AENEX
AEQDE
AEUQT
AEUYR
AFBPY
AFEBI
AFFPM
AFGKR
AFPWT
AFWVQ
AFZJQ
AHBTC
AHEFC
AIACR
AIAGR
AITYG
AIURR
AIWBW
AJBDE
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
ALVPJ
AMBMR
AMYDB
ATUGU
AZBYB
AZVAB
BAFTC
BDRZF
BFHJK
BHBCM
BMXJE
BROTX
BRXPI
BY8
C45
CAG
COF
CS3
D-6
D-7
D-E
D-F
DC6
DCZOG
DPXWK
DR2
DRFUL
DRMAN
DRSTM
DU5
EAD
EAP
EAS
EBC
EBD
EBS
EBX
EGARE
EJD
EMB
EMK
EMOBN
EPT
ESX
EX3
F00
F01
F04
F5P
FEDTE
FUBAC
FZ0
G-S
G.N
GODZA
H.X
HF~
HGLYW
HVGLF
HZI
HZ~
IHE
IX1
J0M
K48
KBYEO
LATKE
LC2
LC3
LEEKS
LH4
LITHE
LOXES
LP6
LP7
LUTES
LW6
LYRES
MEWTI
MK4
MRFUL
MRMAN
MRSTM
MSFUL
MSMAN
MSSTM
MXFUL
MXMAN
MXSTM
N04
N05
N9A
NF~
O66
O9-
OIG
OVD
P2P
P2W
P2X
P2Z
P4B
P4D
PALCI
Q.N
Q11
QB0
Q~Q
R.K
RIWAO
RJQFR
ROL
RX1
SAMSI
SUPJJ
SV3
TEORI
TUS
UB1
V8K
W8V
W99
WBKPD
WHWMO
WIH
WIJ
WIK
WOHZO
WOW
WQJ
WRC
WUP
WVDHM
WXI
WXSBR
XG1
YFH
YUY
ZZTAW
~IA
~WT
AAMMB
AAYXX
AEFGJ
AEYWJ
AGHNM
AGQPQ
AGXDD
AGYGG
AIDQK
AIDYY
AIQQE
CITATION
O8X
CGR
CUY
CVF
ECM
EIF
NPM
7T5
8FD
FR3
H94
K9.
P64
RC3
7X8
ID FETCH-LOGICAL-c3886-e6e119f702c356e412d79c9427aa8f2885012f0df330e1d22108c0ef91f1029b3
IEDL.DBID 24P
ISICitedReferencesCount 5
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=001209433700001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 1351-8216
1365-2516
IngestDate Fri Jul 11 16:12:56 EDT 2025
Tue Oct 07 06:39:24 EDT 2025
Mon Jul 21 06:02:36 EDT 2025
Tue Nov 18 20:56:22 EST 2025
Sat Nov 29 08:03:50 EST 2025
Wed Jan 22 17:17:43 EST 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 4
Keywords haemophilia
models
treatment selection
shared decision‐making
tools
techniques
Language English
License Attribution-NonCommercial-NoDerivs
2024 The Authors. Haemophilia published by John Wiley & Sons Ltd.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c3886-e6e119f702c356e412d79c9427aa8f2885012f0df330e1d22108c0ef91f1029b3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ObjectType-Review-3
content type line 23
ORCID 0000-0002-6913-2808
0000-0002-0205-9722
0009-0001-7385-7297
OpenAccessLink https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fhae.15026
PMID 38684450
PQID 3081484059
PQPubID 2045152
PageCount 14
ParticipantIDs proquest_miscellaneous_3049722753
proquest_journals_3081484059
pubmed_primary_38684450
crossref_citationtrail_10_1111_hae_15026
crossref_primary_10_1111_hae_15026
wiley_primary_10_1111_hae_15026_HAE15026
PublicationCentury 2000
PublicationDate July 2024
2024-07-00
2024-Jul
20240701
PublicationDateYYYYMMDD 2024-07-01
PublicationDate_xml – month: 07
  year: 2024
  text: July 2024
PublicationDecade 2020
PublicationPlace England
PublicationPlace_xml – name: England
– name: Chichester
PublicationTitle Haemophilia : the official journal of the World Federation of Hemophilia
PublicationTitleAlternate Haemophilia
PublicationYear 2024
Publisher Wiley Subscription Services, Inc
Publisher_xml – name: Wiley Subscription Services, Inc
References 2021; 8
2023; 98
2019; 9
2010; 16
2021; 5
2023; 14
2017; 4
2017; 2017
2023; 17
2018; 169
2016; 75
2013; 122
2019; 102
2012; 18
2017; 130
2018; 65
2015; 8
2022; 28
2014; 20
2016; 5
2018; 9
2021; 16
2023
2023; 29
2022; 9
2019; 25
2020; 26
2018
2023; 114
2022; 52
2012; 27
2020; 136
2019; 171
2022; 16
2016; 25
2018; 13
e_1_2_10_23_1
Lanzel AF (e_1_2_10_36_1) 2018; 65
Balen EC (e_1_2_10_42_1) 2016; 25
e_1_2_10_44_1
e_1_2_10_22_1
e_1_2_10_43_1
e_1_2_10_20_1
e_1_2_10_41_1
e_1_2_10_40_1
Stacey D (e_1_2_10_15_1) 2017; 4
Athale A (e_1_2_10_38_1) 2013; 122
CADTH (e_1_2_10_21_1) 2018
e_1_2_10_2_1
e_1_2_10_4_1
e_1_2_10_18_1
e_1_2_10_3_1
e_1_2_10_19_1
e_1_2_10_6_1
e_1_2_10_16_1
e_1_2_10_39_1
e_1_2_10_5_1
e_1_2_10_17_1
e_1_2_10_8_1
e_1_2_10_14_1
e_1_2_10_7_1
Lanzel AF (e_1_2_10_37_1) 2017; 130
e_1_2_10_12_1
e_1_2_10_9_1
e_1_2_10_13_1
e_1_2_10_34_1
e_1_2_10_10_1
e_1_2_10_33_1
e_1_2_10_11_1
e_1_2_10_32_1
e_1_2_10_30_1
Limjoco J (e_1_2_10_24_1) 2023; 98
Hermans C (e_1_2_10_35_1) 2021; 5
Meade L (e_1_2_10_31_1) 2023; 29
e_1_2_10_29_1
e_1_2_10_27_1
e_1_2_10_28_1
e_1_2_10_25_1
e_1_2_10_26_1
References_xml – volume: 5
  issue: 2
  year: 2021
  article-title: Hemophilia treatment in 2021: choosing the“optimal” treatment using an integrative, patient‐oriented approach to shared decision‐making between patients and clinicians (abstract)
  publication-title: Res Pract Thromb Haemost
– volume: 65
  start-page: S132
  year: 2018
  end-page: S133
  article-title: Ethical decision making framework in previously untreated severe hemophilia a patients (abstract)
  publication-title: Ped Blood Cancer
– volume: 29
  start-page: 196
  year: 2023
  end-page: 197
  article-title: Enhancing engagement to support shared decision‐making within haemophilia (abstract PO328)
  publication-title: Haemophilia
– year: 2023
  article-title: Development and useability testing of patient, caregiver and clinician tools to support shared decision making in haemophilia
– volume: 136
  start-page: 17
  year: 2020
  end-page: 18
  article-title: Addressing discordant perceptions and beliefs between patients with hemophilia and their care teams: results from a pilot program to build skills in shared decision‐making (abstract)
  publication-title: Blood
– volume: 8
  start-page: 69
  issue: 1
  year: 2021
  end-page: 79
  article-title: Personalising haemophilia management with shared decision making
  publication-title: J Haemophilia Pract
– volume: 9
  issue: 12
  year: 2019
  article-title: Key components of shared decision making models: a systematic review
  publication-title: BMJ Open
– volume: 17
  start-page: 249
  year: 2023
  end-page: 257
  article-title: Shared decision‐making in hemophilic arthropathy rehabilitation: a qualitative study
  publication-title: Patient Prefer Adherence
– volume: 17
  start-page: 1093
  year: 2023
  end-page: 1105
  article-title: Gene therapy for hemophilia A: a mixed methods study of patient preferences and shared decision‐making
  publication-title: Patient Prefer Adherence
– volume: 16
  start-page: 1439
  year: 2022
  end-page: 1447
  article-title: The hemophilia gene therapy patient journey: questions and answers for shared decision‐making
  publication-title: Patient Pref Adher
– volume: 130
  start-page: 5583
  year: 2017
  article-title: Ethical decision making framework in previously untreated severe hemophilia a patients (abstract)
  publication-title: Blood
– volume: 16
  start-page: 20
  issue: 1
  year: 2010
  end-page: 32
  article-title: A study of variations in the reported haemophilia A prevalence around the world
  publication-title: Haemophilia
– volume: 9
  start-page: 239
  issue: 8
  year: 2018
  end-page: 249
  article-title: The role of patient and healthcare professionals in the era of new hemophilia treatments in developed and developing countries
  publication-title: Thera Adv Hematol
– volume: 14
  year: 2023
  article-title: Considerations for shared decision management in previously untreated patients with hemophilia A or B
  publication-title: Ther Adv Hematol
– volume: 114
  year: 2023
  article-title: What does shared decision making ask from doctors? Uncovering suppressed qualities that could improve person‐centered care
  publication-title: Patient Educ Couns
– volume: 25
  start-page: 938
  issue: 6
  year: 2019
  end-page: 945
  article-title: Patient‐centred care in haemophilia: patient perspectives on visualization and participation in decision‐making
  publication-title: Haemophilia
– year: 2018
– volume: 29
  start-page: 1184
  issue: 5
  year: 2023
  end-page: 1190
  article-title: Development of a haemophilia A gene therapy shared decision‐making tool for clinicians
  publication-title: Haemophilia
– volume: 16
  start-page: 189
  issue: 1
  year: 2021
  article-title: Optimizing language for effective communication of gene therapy concepts with hemophilia patients: a qualitative study
  publication-title: Orphanet J Rare Dis
– volume: 65
  issue: 2
  year: 2018
  article-title: Gene therapy for hemophilia
  publication-title: Pediatr Blood Cancer
– volume: 122
  start-page: 1748
  issue: 21
  year: 2013
  article-title: Developing a two‐sided intervention to facilitate shared decision making in haemophilia: decision boxes for clinicians and brief patient decision aids for patients (abstract)
  publication-title: Blood
– volume: 52
  year: 2022
  article-title: Hemophilia treatment in 2021: choosing the “optimal” treatment using an integrative, patient‐oriented approach to shared decision‐making between patients and clinicians
  publication-title: Blood Rev
– volume: 2017
  start-page: 595
  issue: 1
  year: 2017
  end-page: 604
  article-title: Using pharmacokinetics to individualize hemophilia therapy
  publication-title: Hematology Am Soc Hematol Educ Program
– volume: 169
  start-page: 467
  issue: 7
  year: 2018
  end-page: 473
  article-title: PRISMA Extension for Scoping Reviews (PRISMA‐ScR): checklist and explanation
  publication-title: Ann Intern Med
– volume: 25
  start-page: 196
  issue: 1
  year: 2016
  article-title: Moving toward patient‐centred care in haemophilia: understanding patients' needs
  publication-title: Qual Life Res
– volume: 8
  start-page: 527
  year: 2015
  end-page: 534
  article-title: Joining the patient on the path to customized prophylaxis: one hemophilia team explores the tools of engagement
  publication-title: J Multidiscip Healthc
– volume: 18
  start-page: e91
  issue: 3
  year: 2012
  end-page: 94
  article-title: A study of variations in the reported haemophilia B prevalence around the world
  publication-title: Haemophilia
– volume: 9
  start-page: 49
  issue: 2
  year: 2018
  end-page: 61
  article-title: Novel therapies and current clinical progress in hemophilia A
  publication-title: Ther Adv Hematol
– volume: 26
  start-page: 1
  issue: 6
  year: 2020
  end-page: 158
  article-title: WFH guidelines for the management of hemophilia
  publication-title: Haemophilia
– volume: 28
  start-page: 784
  issue: 5
  year: 2022
  end-page: 795
  article-title: The GOAL‐Hēm journey: shared decision making and patient‐centred outcomes
  publication-title: Haemophilia
– volume: 13
  issue: 2
  year: 2018
  article-title: The quality of instruments to assess the process of shared decision making: a systematic review
  publication-title: PLoS One
– volume: 102
  start-page: 1
  issue: 1
  year: 2019
  end-page: 2
  article-title: Patient‐centered decision‐making
  publication-title: Patient Educ Couns
– volume: 20
  start-page: 800
  issue: 6
  year: 2014
  end-page: 806
  article-title: Developing a two‐sided intervention to facilitate shared decision‐making in haemophilia: decision boxes for clinicians and patient decision aids for patients
  publication-title: Haemophilia
– year: 2023
– year: 2023
  article-title: Awareness of individual goals, preferences, and priorities of persons with severe congenital haemophilia A for a tailored shared decision‐making approach to liver‐directed gene therapy. A practical guideline
  publication-title: Blood Rev
– volume: 25
  start-page: 616
  issue: 4
  year: 2019
  end-page: 625
  article-title: UK vs US physician decision‐making in the treatment of haemophilia
  publication-title: Haemophilia
– volume: 75
  start-page: 40
  year: 2016
  end-page: 46
  article-title: PRESS peer review of electronic search strategies: 2015 guideline statement
  publication-title: J Clin Epidemiol
– volume: 5
  start-page: 1386
  issue: 1
  year: 2016
  article-title: Information provision and attentive listening as determinants of patient perceptions of shared decision‐making around chronic illnesses
  publication-title: Springerplus
– volume: 9
  start-page: 156
  issue: 1
  year: 2022
  end-page: 166
  article-title: The journey of gene therapy in hemophilia—putting the patient at the centre of the hub and spoke model
  publication-title: J Haem Pract
– volume: 27
  start-page: 1361
  issue: 10
  year: 2012
  end-page: 1367
  article-title: Shared decision making: a model for clinical practice
  publication-title: J Gen Intern Med
– volume: 171
  start-page: 540
  issue: 8
  year: 2019
  end-page: 546
  article-title: Establishing the prevalence and prevalence at birth of hemophilia in males
  publication-title: Ann Intern Med
– volume: 98
  start-page: E65
  year: 2023
  end-page: E66
  article-title: Shared decision‐making for hemophilia gene therapy: patient perspectives and expectations (abstract)
  publication-title: Am J Hematol
– volume: 4
  issue: 4
  year: 2017
  article-title: Decision aids for people facing health treatment or screening decisions
  publication-title: Cochrane Database Syst Rev
– ident: e_1_2_10_44_1
– ident: e_1_2_10_34_1
  doi: 10.2147/PPA.S355627
– ident: e_1_2_10_18_1
  doi: 10.1136/bmjopen-2019-031763
– ident: e_1_2_10_19_1
  doi: 10.1371/journal.pone.0191747
– ident: e_1_2_10_27_1
  doi: 10.1182/blood-2020-136728
– ident: e_1_2_10_10_1
  doi: 10.1177/2040620718784830
– ident: e_1_2_10_41_1
  doi: 10.2478/jhp-2022-0021
– ident: e_1_2_10_7_1
  doi: 10.1177/2040620717746312
– volume: 65
  start-page: S132
  year: 2018
  ident: e_1_2_10_36_1
  article-title: Ethical decision making framework in previously untreated severe hemophilia a patients (abstract)
  publication-title: Ped Blood Cancer
– volume: 98
  start-page: E65
  year: 2023
  ident: e_1_2_10_24_1
  article-title: Shared decision‐making for hemophilia gene therapy: patient perspectives and expectations (abstract)
  publication-title: Am J Hematol
– ident: e_1_2_10_26_1
  doi: 10.1186/s13023-020-01555-w
– ident: e_1_2_10_30_1
  doi: 10.2147/JMDH.S93579
– ident: e_1_2_10_5_1
  doi: 10.1111/j.1365-2516.2009.02127.x
– ident: e_1_2_10_39_1
  doi: 10.1111/hae.12495
– ident: e_1_2_10_32_1
  doi: 10.1111/hae.14822
– ident: e_1_2_10_40_1
– ident: e_1_2_10_13_1
  doi: 10.1016/j.blre.2023.101118
– ident: e_1_2_10_20_1
  doi: 10.1016/j.jclinepi.2016.01.021
– ident: e_1_2_10_2_1
  doi: 10.1016/j.blre.2021.100890
– ident: e_1_2_10_4_1
  doi: 10.7326/M19-1208
– ident: e_1_2_10_22_1
  doi: 10.7326/M18-0850
– ident: e_1_2_10_25_1
  doi: 10.2147/PPA.S394095
– ident: e_1_2_10_3_1
  doi: 10.1111/hae.14046
– volume: 29
  start-page: 196
  year: 2023
  ident: e_1_2_10_31_1
  article-title: Enhancing engagement to support shared decision‐making within haemophilia (abstract PO328)
  publication-title: Haemophilia
– ident: e_1_2_10_11_1
  doi: 10.17225/jhp00178
– volume-title: Grey matters: a practical tool for searching health‐related grey literature [Internet]
  year: 2018
  ident: e_1_2_10_21_1
– ident: e_1_2_10_33_1
  doi: 10.1111/hae.14608
– volume: 4
  issue: 4
  year: 2017
  ident: e_1_2_10_15_1
  article-title: Decision aids for people facing health treatment or screening decisions
  publication-title: Cochrane Database Syst Rev
– ident: e_1_2_10_9_1
  doi: 10.1182/asheducation-2017.1.595
– ident: e_1_2_10_23_1
  doi: 10.2147/PPA.S406894
– ident: e_1_2_10_8_1
  doi: 10.1002/pbc.26865
– volume: 130
  start-page: 5583
  year: 2017
  ident: e_1_2_10_37_1
  article-title: Ethical decision making framework in previously untreated severe hemophilia a patients (abstract)
  publication-title: Blood
– volume: 122
  start-page: 1748
  issue: 21
  year: 2013
  ident: e_1_2_10_38_1
  article-title: Developing a two‐sided intervention to facilitate shared decision making in haemophilia: decision boxes for clinicians and brief patient decision aids for patients (abstract)
  publication-title: Blood
– ident: e_1_2_10_43_1
  doi: 10.1111/hae.13830
– ident: e_1_2_10_29_1
  doi: 10.1186/s40064-016-3086-4
– ident: e_1_2_10_6_1
  doi: 10.1111/j.1365-2516.2011.02588.x
– ident: e_1_2_10_12_1
  doi: 10.1177/20406207231165857
– volume: 25
  start-page: 196
  issue: 1
  year: 2016
  ident: e_1_2_10_42_1
  article-title: Moving toward patient‐centred care in haemophilia: understanding patients' needs
  publication-title: Qual Life Res
– ident: e_1_2_10_17_1
  doi: 10.1016/j.pec.2023.107801
– ident: e_1_2_10_28_1
  doi: 10.1111/hae.13766
– ident: e_1_2_10_16_1
  doi: 10.1016/j.pec.2018.11.005
– ident: e_1_2_10_14_1
  doi: 10.1007/s11606-012-2077-6
– volume: 5
  issue: 2
  year: 2021
  ident: e_1_2_10_35_1
  article-title: Hemophilia treatment in 2021: choosing the“optimal” treatment using an integrative, patient‐oriented approach to shared decision‐making between patients and clinicians (abstract)
  publication-title: Res Pract Thromb Haemost
SSID ssj0013206
Score 2.4314446
SecondaryResourceType review_article
Snippet Introduction Treatment selection in haemophilia is increasingly challenging given evolving therapeutic options and the need for individualization. Shared...
Treatment selection in haemophilia is increasingly challenging given evolving therapeutic options and the need for individualization. Shared decision-making...
IntroductionTreatment selection in haemophilia is increasingly challenging given evolving therapeutic options and the need for individualization. Shared...
SourceID proquest
pubmed
crossref
wiley
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 880
SubjectTerms Decision making
Decision Making, Shared
haemophilia
Hemophilia
Hemophilia A - therapy
Humans
Patient Participation
Patients
Shared decision making
techniques
treatment selection
Title Shared decision‐making related to treatment of haemophilia: A scoping review of influential factors and available support tools
URI https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fhae.15026
https://www.ncbi.nlm.nih.gov/pubmed/38684450
https://www.proquest.com/docview/3081484059
https://www.proquest.com/docview/3049722753
Volume 30
WOSCitedRecordID wos001209433700001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVWIB
  databaseName: Wiley Online Library Full Collection 2020
  customDbUrl:
  eissn: 1365-2516
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0013206
  issn: 1351-8216
  databaseCode: DRFUL
  dateStart: 19970101
  isFulltext: true
  titleUrlDefault: https://onlinelibrary.wiley.com
  providerName: Wiley-Blackwell
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9QwEB6VFiEuvB8LpTKIA5eg-JHYhtMKuuoBqgpRaW-Rk9jqSttk1ez2DP-A38gvYcbJRq0ACYlLZMkT24ln7G_8mA_gNUUN01yExDiTJypUmMqNTISw3vmszEtTRrIJfXxs5nN7sgPvt3dh-vgQ44IbWUYcr8nAXdldMfIz598imhH5DdjjXGpSaaFOrmwhRGJNYqBLjOD5EFaIjvGMr16fjH5DmNcBa5xxZnf_q6334M4ANNm014z7sOObB3Dr87CV_hC-U6hmX7N6INn5-e3HeWSmYvF6C-asWzYeQ2dtYFj8ebuiBRj3jk0Z3WfpxWl3gQQWPeEJjhlLNvD4MNfUzF26xZKuaLFusyK8j0W3y-4RnM4Ov344SgY-hqSSBnvS555zG3QqKpnlXnFRa1tZJbRzJghjMpztQloHKVPPa4HepKlSHywPCGNsKR_DbtM2_imwFFGjCRT_SwWKWF86nqNqaJ45iyNQNYE3244pqiFYOXFmLIut04LfXMRfOoFXo-iqj9DxJ6H9be8Wg5F2hUQ4pNDBzewEXo7ZaF60Z-Ia325IRlktBDp1E3jSa8VYi0StVipLsbGx8_9efXE0PYyJZ_8u-hxuCwRQ_dHgfdhdX2z8C7hZXa4X3cVB1HV86rk5gL2PX2ann34BQ-YC4w
linkProvider Wiley-Blackwell
linkToHtml http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3NbtQwEB6VLaJc-KcsFDCIA5eg2HESG3FZQVeL2K4QaqXeIiexxUrbZNXd7RnegGfkSZhxvFErQELiZskTO8nM2N_4Zz6AV5Q1LOfCRcqoLJKuwlKmkkgIbY1Ny6xUpSebyGczdXqqP-_Au-1dmC4_RL_gRp7hx2tycFqQvuTlX419g3BGZNdgV6IZpQPY_fBlfDK9tIvguTWJhC5SgmchsxCd5Okfvjof_QYyr2JWP-mMb__f696BWwFsslFnHXdhxzb34MZR2E6_D98pXbOtWR2Idn5--3Hm2amYv-KCNeuW9UfRWesYNn_WLmkRxrxlI0Z3Wjpx2mEggXlHeoLjxoIFLh9mmpqZCzNf0DUtttosCfNj0-1i9QBOxofH7ydR4GSIqkShNm1mOdcuj0WVpJmVXNS5rrQUuTHKCaVSnPFcXLskiS2vBUaUqoqt09whlNFl8hAGTdvYR8BiRI7KUQ4w6ShrfWl4huaR89RoHIWqIbzeaqaoQsJy4s1YFNvABb-58L90CC970WWXpeNPQgdb9RbBUVdFgpBIYpCb6iG86KvRxWjfxDS23ZCM1LkQGNgNYb8zi76XBC1byjTGl_Xa_3v3xWR06AuP_130OexNjo-mxfTj7NMTuCkQUHVHhQ9gsD7f2KdwvbpYz1fnz4Lp_wIjSgXY
linkToPdf http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1NT9wwEB0BrVAvpS20bKHFrThwCYodJ7ERlxVlBWq72kMrcYucxFZXWpIVu8uZ_gN-I7-kM042ArVISL1Z8sRO4hn7-es9gH1iDUu5cIEyKgmkKzCVqCgQQltj4zzJVe7FJtLhUF1c6NEKHC_vwjT8EN2CG0WG768pwO20dPei_JexhwhnRLIKz2SMfSzxOsvRvT0Er6xJEnSBEjxpeYXoHE_36MPR6C-I-RCx-iFnsPF_L_sKXrZQk_Ub33gNK7Z6A-vf2830TfhNZM22ZGUrs3N3c3vptamYv-CCOfOadQfRWe0YFn9ZT2kJxhyxPqMbLY057S-QwbiRPMFeY8JaJR9mqpKZazOe0CUtNltMCfFj0fVktgU_B6c_Ts6CVpEhKCKFbWkTy7l2aSiKKE6s5KJMdaGlSI1RTigV43jnwtJFUWh5KXA-qYrQOs0dAhmdR29hraoruw0sRNyoHDGASUec9bnhCTpHymOjsQ8qenCwbJmsaOnKSTVjki2nLfjNmf-lPfjcmU4bjo5_Ge0umzdrw3SWRQiIJE5xY92DT102BhjtmpjK1guykToVAqd1PXjXuEVXS4R-LWUc4sv61n-8-uysf-oT759uugfroy-D7Nv58OsOvBCIpppzwruwNr9a2A_wvLiej2dXH73f_wEACwPB
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Shared+decision-making+related+to+treatment+of+haemophilia%3A+A+scoping+review+of+influential+factors+and+available+support+tools&rft.jtitle=Haemophilia+%3A+the+official+journal+of+the+World+Federation+of+Hemophilia&rft.au=Sun%2C+Haowei+Linda&rft.au=Klaassen%2C+Robert+J&rft.au=Anger%2C+Dana+L&rft.au=Mendell%2C+Ari+L&rft.date=2024-07-01&rft.issn=1365-2516&rft.eissn=1365-2516&rft.volume=30&rft.issue=4&rft.spage=880&rft_id=info:doi/10.1111%2Fhae.15026&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1351-8216&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1351-8216&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1351-8216&client=summon